Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 9 studies | 45% ± 23% | |
glutamatergic neuron | 8 studies | 35% ± 17% | |
interneuron | 6 studies | 43% ± 21% | |
endothelial cell | 4 studies | 28% ± 12% | |
retinal ganglion cell | 4 studies | 41% ± 21% | |
GABAergic interneuron | 3 studies | 39% ± 16% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 37% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 98% | 147.29 | 643 / 653 | 82% | 11.76 | 498 / 605 |
kidney | 90% | 67.52 | 80 / 89 | 80% | 4.84 | 722 / 901 |
prostate | 95% | 86.67 | 233 / 245 | 30% | 0.70 | 152 / 502 |
brain | 85% | 34.44 | 2235 / 2642 | 35% | 0.88 | 244 / 705 |
adrenal gland | 63% | 21.56 | 162 / 258 | 55% | 1.98 | 127 / 230 |
lung | 87% | 69.76 | 501 / 578 | 22% | 0.79 | 256 / 1155 |
breast | 92% | 53.60 | 422 / 459 | 16% | 0.38 | 184 / 1118 |
bladder | 95% | 49.14 | 20 / 21 | 13% | 0.42 | 65 / 504 |
uterus | 94% | 76.62 | 159 / 170 | 13% | 0.50 | 59 / 459 |
skin | 46% | 49.79 | 824 / 1809 | 60% | 4.48 | 285 / 472 |
blood vessel | 96% | 96.80 | 1283 / 1335 | 0% | 0 | 0 / 0 |
adipose | 88% | 62.72 | 1057 / 1204 | 0% | 0 | 0 / 0 |
heart | 78% | 37.13 | 668 / 861 | 0% | 0 | 0 / 0 |
intestine | 63% | 33.51 | 613 / 966 | 10% | 0.34 | 54 / 527 |
esophagus | 68% | 30.96 | 986 / 1445 | 4% | 0.05 | 7 / 183 |
ovary | 62% | 28.59 | 111 / 180 | 5% | 0.13 | 21 / 430 |
eye | 0% | 0 | 0 / 0 | 57% | 3.06 | 46 / 80 |
pancreas | 33% | 8.85 | 108 / 328 | 15% | 0.26 | 26 / 178 |
liver | 28% | 7.53 | 63 / 226 | 18% | 0.71 | 75 / 406 |
stomach | 34% | 10.66 | 123 / 359 | 6% | 0.20 | 16 / 286 |
muscle | 38% | 10.82 | 304 / 803 | 0% | 0 | 0 / 0 |
spleen | 12% | 2.40 | 28 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.42 | 3 / 45 |
peripheral blood | 1% | 0.25 | 10 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008150 | Biological process | biological_process |
GO_0016020 | Cellular component | membrane |
GO_0005575 | Cellular component | cellular_component |
GO_0003674 | Molecular function | molecular_function |
Gene name | PTCHD4 |
Protein name | Patched domain-containing protein 4 (p53-regulated patched protein) Patched domain containing 4 |
Synonyms | C6orf138 PTCH53 |
Description | FUNCTION: Could act as a repressor of canonical hedgehog signaling by antagonizing the effects of SMO, as suggested by down-regulation of hedgehog target genes, including GLI1, PTCH1, and PTCH2 in PTCHD4-expressing cells. . |
Accessions | ENST00000339488.9 [Q6ZW05-3] Q6ZW05 ENST00000398738.3 ENST00000679966.1 H0Y3Q6 A0A7P0TAD5 |